This post has expired! It was posted more than 90 days ago.
<- Back

130853 - Addressing Sleep Onset and Maintenance Issues: Alternatives to Conventional Therapy

  • : Online
Relevance to General Practice

Insomnia is the most prevalent complaint in clinical practice with inadequate sleep of either duration or quality affecting between 33% and 45% of Australian adults. Significant insomnia is believed to affect 20% of Australian adults. Sleep problems such as insomnia produce a considerable burden on public health, social life and workplace functioning which have been on the increase since 2010. 

Insomnia has been shown to increase the risk of developing hypertension, type 2 diabetes, obesity and metabolic syndrome. Sleep disorders can also reduce normal immune function, increasing the risk of infections and cancer. Disturbances in mood, thinking, concentration, memory, learning and reaction times have also been reported in patients with sleep disorders. Workplace performance and productivity are decreased in those with insomnia, and it is also associated with increased motor vehicle accidents, falls and overall decreased survival rates.

Learning outcomes
  • Distinguish between the modes of action of benzodiazepines, benzodiazepine receptor agonists and more novel therapies to address sleep onset and maintenance
  • Describe the role of novel therapies in the management of chronic insomnia
  • Identify patients with insomnia who would be appropriate for switching to novel therapies
  • Counsel patients regarding the potential risks associated with long term use of benzodiazepines and benzodiazepine receptor agonists(‘Z-drugs’), and how to swit
  • Delivery
    130853 - Addressing Sleep Onset and Maintenance Issues: Alternatives to Conventional Therapy
    1.5 hours
    Start Date
    End Date
    CPD Points
    1.5 hours
    Contact Phone
    Log in into view this field.